Group
1 Heterogenous group of chemical compounds.
Despite the continuous improvement in the production of synthetic drugs, herbal compounds still have considerable use, but the important ones come from commercial plantings. The consumption of popular species is high, and it is impossible to cover it only by collecting wild plants. Bred varieties generally provide higher yields and reduce the risk of confusion or falsification [ 40 , 41 ]. Nowadays, the collector often encounters difficulties that were not present before, such as chemical damage or contamination of the growing plants [ 167 ]. The composition and total content of complex active constituents are variable during plant development and vegetative growth. Choosing a suitable period for harvesting or collecting is essential. Plants should not be harvested in humid or rainy weather, but only when dry. During harvesting, the plants must not be damaged because breaking the leaves sometimes affects the active compounds in an undesirable manner. Many compounds, such as vitamin C or tannins, can also react with metals. Therefore, if possible, the plants or parts are collected in their entirety. The leaves and stems are usually harvested just before flowering or during flowering. The flowers are harvested shortly before full development, but some may still be in the bud stage. The fruits and seeds are harvested at the time of full ripeness. For roots and rhizomes, the suitable period is the developmental dormancy of the plant, which is usually autumn or spring. The bark is harvested in the temperate zone at the beginning of vegetative growth in early spring, or, in the tropics, throughout the year [ 168 , 169 ].
The extraction of plant material to produce an effective drug usually involves many technical steps. Contaminants on aboveground parts can be removed by sieving or winnowing, while underground organs are decontaminated by washing and brushing. The common method of preservation continues to be drying, preceded by fermentation in some cases. By removing water, enzymes are inactivated, and the growth of fungi and bacteria is limited [ 170 , 171 ]. Most plants should be dried in the shade, and the temperature should not exceed a specific limit. For plants containing volatile essential oils, this limit is 40 °C [ 172 , 173 ]. Freeze-drying or lyophilization is also frequently used. For this method, fresh plant material is rapidly frozen at a temperature of −20 °C to −50 °C and then dried under a high vacuum. However, in some cases, freeze-drying imperfectly preserves important classes of medicinal compounds such as phenolics and volatile substances, reducing the effectiveness of some plant drugs. Additionally, the material dried in this way is very hygroscopic [ 174 , 175 ]. Freeze-dried drugs have to be stored away from moisture, as well as dust, insects, and light [ 172 , 173 ]. The drug is usually processed or cut after drying. Active compounds are used either directly in the form of medicinal products or indirectly as raw materials to obtain active compounds, which become part of medicinal products. Medicinal products produced directly from drugs can be in the form of tea for water infusion, granules, tablets, extracts, and divided or undivided powders. Active compounds are obtained from herbal materials often by extraction (alkaloids, glycosides), distillation (essential oils), or pressing (oils, fats) [ 176 , 177 ].
6.3.1. ginseng ( panax ginseng ).
As a drug, ginseng is prepared in two different ways, which affect the content of active components and the degree of medicinal effects. It can be modified either by peeling and drying the root, after which it is called white ginseng, or the root can be steamed without peeling when it is referred to as the “hotter” red ginseng [ 215 ].
Ginsenosides have been shown to stimulate nitric oxide (NO) production in several systems. Purified ginsenoside Rb 1 induced NO production in human aortic endothelial cells in vitro. The effect on the NO pathway is responsible for ginseng’s vasorelaxant and mildly hypotensive effect [ 182 ].
Ginseng increased the activity of the antioxidant enzymes superoxide dismutase and glutathione peroxidase in rats in vivo. Thus, supplementation may prevent increased oxidant accumulation and age-related oxidative protein and nucleic acid damage [ 178 ]. Experimental data from tests on male chicks suggest that Rb 1 may improve memory for the task of visual discrimination and that the nootropic effect may be associated with changes in anxiety [ 179 ]. Ginsenoside Rb 1 also reduced simulated Alzheimer’s disease in a rat model. Thus, it could be used in the future as a therapeutic agent for patients with memory impairment [ 180 ]. Ginsenoside Rg 1 supplementation improved the performance of old mice in the behavioral test, significantly increasing the expression of proteins associated with synaptic plasticity in the hippocampus, including synaptophysin and N -methyl- D -aspartate receptor subunit 1 [ 181 ]. Oral administration of a combination of Ginkgo biloba and Panax ginseng extracts improved memory in rats. Data on test drug effects suggested the involvement of a serotonergic transporter as an important neurochemical correlate of rat behavior and memory effects of study drugs [ 216 ].
Ginseng’s effect on the human body can be described as adaptogenic. It increased the physical and mental resilience of the organism, eliminated fatigue, and helped the body to adapt to any current needs [ 217 ]. It is recommended to use a standardized ginseng extract at a dose of 200 mg per day ginseng for an extended period of time. Standardization refers to the content of ginsenosides, which usually ranges from 1.5 to 7 percent. Alternatively, 0.5 to 2 g of dry root per day is recommended, with ginseng taken in tea or chewed [ 218 ]. Ginseng is contraindicated in patients with acute asthma and hypertension. In large doses, it can cause excessive body stimulation, restlessness, insomnia, increased blood pressure, nervousness, inability to concentrate, headaches, and nosebleeds [ 218 , 219 ].
The leaves and ripe fruit are harvested from spring to early autumn. Leaves are used to make alcohol extracts (tinctures) or dried and ground [ 220 ]. Hulled and roasted ginkgo kernels are also consumed [ 221 ]. Mechanisms of action of Ginkgo biloba compounds include free radical scavenging for antioxidant activity, antagonistic effects on platelet-activating factor, vasodilation, and an overall reduction in blood viscosity [ 183 , 187 ].
Results of an ex vivo rat experiment showed that Ginkgo biloba extract had specific neuroprotective effects that may be useful in treating chronic cerebral hypoperfusion. The extract’s pharmacological mechanism involved modulating inflammatory mediators and the cholinergic system [ 184 ]. The triterpene lactones (ginkgolides A, B, C, and bilobalide) in the Ginkgo biloba extract have antioxidant, anti-inflammatory, and neuroprotective effects. In addition, in an experiment on mice, the extract had an antagonistic effect on glycine and GABA type A receptors [ 185 ].
A double-blind, placebo-controlled clinical trial in which participants received validated neuropsychological tests before and after treatment with Ginkgo biloba extract indicated significant improvement in working memory and information processing speed [ 186 ]. In contrast, a critical review of the evidence from several randomized clinical trials did not provide convincing evidence that Ginkgo biloba extracts taken either in a single dose or over a long time had a positive effect on any aspect of cognitive performance in healthy human subjects under sixty years of age [ 222 ].
Still, Ginkgo biloba extracts are widely prescribed to treat cerebral dysfunction and neurological disorders. Doses of 120–300 mg of standardized Ginkgo biloba 761 extracts (24% flavone glycosides and 6% terpene lactones) per day should be administered [ 183 , 223 , 224 ]. No side effects have been reported at regular doses, but mild stomach irritation and headaches occasionally occur with excessive consumption. It causes blood thinning, so people taking some anticoagulants should not take the drug before surgery [ 219 , 225 ].
Centella’s use in traditional medicine is diverse and varies regionally. In the countries of origin, fresh leaves are consumed as a salad, as part of curry spice mixes, or cooked as a vegetable [ 226 ].
An ethanol extract of C. asiatica mediated protection against amyloid-β-induced aggregated neurotoxicity by modulating the antioxidant defense system in cells in vitro, including superoxide dismutase, catalase, glutathione peroxidase, glutathione reductase, and glutathione and glutathione disulfide levels. C. asiatica is a traditional medicinal herb with strong antioxidant activity that reduces amyloid-β deposition in the brain. Amyloid-β is the major component of senile plaques and neurofibrillary tangles found in the brains of patients with Alzheimer’s disease. This highlights the potential therapeutic and preventive value of C. asiatica in treating Alzheimer’s disease [ 189 ].
The results from in vivo experiments on rats in a maze, monitoring social interactions, locomotor activity, and cage tests, showed that pure asiaticoside, and methanol or ethyl acetate extracts of Centella asiatica had anxiolytic activity. In addition, asiaticoside did not affect locomotor activity, suggesting that this compound does not have sedative effects [ 227 ]. Another in vivo study in mice revealed that a NO modulating mechanism may be involved in the protective effect of Centella asiatica against anxiety caused by sleep deprivation, oxidative damage, and neuroinflammation [ 188 ]. A study in juvenile and young adult mice demonstrated the nootropic effect of an aqueous extract of C. asiatica . Treatment resulted in increased hippocampal acetylcholinesterase activity and dendritic arborization of hippocampal CA3 neurons. Thus, treatment with C. asiatica during the postnatal developmental stage can affect neuronal morphology and support brain function [ 190 ].
The reported typical daily dose of C. asiatica is approximately 600 mg of dried leaves, or from 60 mg to 120 mg of standardized extract of C. asiatica (contains at least 85% of triterpenoid glycosides) [ 228 , 229 ].
Based on clinical studies, the reported tolerability of orally administered extracts of Centella is high, and no interactions with other drugs are known. Although no teratogenic effects have been reported, the drug should not be used during pregnancy and lactation. Use by children is also not recommended [ 230 ].
The roots and the leaves are harvested and used mainly in dried form. An infusion is prepared from the leaves and a decoction from the root. Fruit is sometimes used as an emetic [ 231 ].
A study in mice indicated that ashwagandha increased the content of hemoglobin, platelets, and red as well as white blood cells. An increase in red blood cells increases the blood’s ability to transport oxygen to the peripheral system, ensuring greater maximum aerobic capacity [ 194 ]. In another study, rats were used as a model of tardive dyskinesia, a disorder characterized by involuntary neurological triggering that leads to spontaneous, repetitive body movements, such as grimacing, sticking out the tongue, or lip movements that were simulated by injection of reserpine. Oxidative stress and lipid peroxidation products are involved in the pathophysiology of this disease. Long-term administration of Withania somnifera root extract to the rats significantly reduced lipid peroxidation, restored reduced glutathione levels, and reversed the decrease in brain superoxide dismutase and catalase levels induced by reserpine treatment. Thus, Withania somnifera root extract could be a helpful drug for treating drug-induced tardive dyskinesia [ 192 ]. Several tests in animal models have confirmed the nootropic effect of ashwagandha and its potential as a treatment for Alzheimer’s disease [ 191 , 193 ]. In another study, the steroidal lactone withaferin, a bioactive compound from the group of withanolides showed significant anticancer properties both in vitro and in vivo [ 232 ].
The dosage can be from 6 to 10 g of ground roots of ashwagandha per day or the equivalent of 750 mg to 1250 mg of extract per day [ 233 ]. Ashwagandha is not recommended in cases of hyperthyroidism or pregnancy. It is a relatively safe drug when used at the recommended doses. Overdoses can cause gastrointestinal problems and vomiting; therefore, treatment should be started with small doses and gradually increased. Ashwagandha is best taken in the evening because, in substantial doses, the herbal extract can act as a sedative [ 234 ].
In countries of natural occurrence, it is sometimes used as a leafy vegetable in salads or soups [ 235 ].
In vitro treatment of rat astrocytes with methanol extract of Bacopa monnieri significantly reduced damage caused by high NO concentrations. It has been suggested that glial cells may produce NO by an enzyme-independent mechanism when stimulated by superoxide radicals, and the study results verified the antioxidant activity of Brahmi plant extract [ 196 ].
Treatment of albino rats with an alcoholic extract of Bacopa monnieri increased protein kinase activity and caused an increase in protein in the hippocampus. Overall, the extract has improved learning ability by enhancing cognitive function and memory retention. The chemical compounds responsible for this facilitating effect have been identified as a mixture of two saponins, bacosides A and B [ 197 ]. Choline acetyltransferase expression in the hippocampus was studied in olfactory bulbectomy mice compared to controls. Olfactory bulbectomy reduced cholinergic activity and thus choline acetyltransferase expression in the hippocampus. However, subsequent administration of Bacopa monnieri alcohol extract reversed this effect and gradually improved the induced cognitive dysfunction [ 195 ]. In a rat model of Alzheimer’s disease, Bacopa monnieri alcohol extract improved escape latency in the Morris water maze test. In addition, the loss of neurons and the density of cholinergic neurons were also mitigated [ 198 ]. Experiments have shown inhibition of the degeneration of cholinergic neurons by Bacopa monnieri , suggesting that the herb is a cognitive enhancer and neuroprotectant and may serve as a potential adjunctive drug for treating Alzheimer’s disease [ 195 , 198 ].
The Bacopa monnieri liquid extract dosage (ratio 1:2) is 5–12 mL per day for adults and 2.5–6 mL per day for children aged 6–12 years. For Bacopa monnieri extracts standardized at 20% content of bacosides A and B, 200–400 mg in divided doses for adults and 100–200 mg daily in divided doses for children is recommended [ 236 , 237 ].
No serious side effects have been reported. Rarely, mild sedation or digestive problems may occur after ingestion [ 238 , 239 ].
The seeds, the so-called guarana nuts, are harvested at full maturity. They are first roasted, then sifted by sieving, mechanically crushed, and mixed with water to make a bitter paste with high caffeine content. A coffee-like beverage is prepared by simmering guarana paste with hot water. Guarana paste is also added to syrups, and various non-alcoholic and alcoholic drinks are prepared from it, mainly popular in Brazil. Sometimes, the guarana paste is dried, ground into a powder, and used to make tablets [ 240 , 241 ].
In an in vivo study, the aqueous fraction of Paullinia cupana seeds was repeatedly administered to rats who were then placed in a T-maze, a model of generalized anxiety and panic disorders, and the guarana was shown to have anxiolytic and panicolytic effects [ 242 ]. The impact of long-term administration of Paullinia cupana seed extract by gavage to rats at various doses on their cognitive behavior was studied using the Morris water maze test, which showed identical results in rats with scopolamine-induced amnesia compared with controls [ 200 ]. Mice that ingested guarana suspension showed a significant increase in physical capacity when exposed to stressful situations such as forced swimming. After both single and chronic administration, guarana partially reversed the amnesic effect of scopolamine, as measured by a passive avoidance test in rats and mice, indicating a positive impact on memory acquisition [ 199 ]. Studies have shown that oral administration of processed Paullinia cupana seeds had a significant nootropic effect. Herbal drugs that exhibit this property may offer a useful adjunct therapeutic option for preventing or treating memory deficits, such as those seen in Alzheimer’s or Parkinson’s disease [ 199 , 200 ].
A typical dose is 75 mg of guarana extract (approximately 12% caffeine) administered as a tablet [ 243 ]. Guarana should not be used in persons with cardiovascular disease, who are pregnant or breastfeeding, have chronic headaches, diabetes, insomnia, mental disorders, stomach ulcers, or are taking theophylline [ 244 ].
The root is ground to a powder and formed into tablets or used in the form of a tincture. Infusion of the above-ground parts is also sometimes used [ 245 ].
In vitro experiments showed the antioxidant and antiradical activity of eleuthero [ 208 ], including the inhibition of lipid peroxidation [ 207 ].
In an in vivo study, an aqueous extract of eleuthero reduced acute stress in mice [ 210 ]. A study in normal mice examined the effects of an aqueous extract from eleuthero leaves on memory function. These in vivo tests showed that oral administration of the extract improved memory functions, and ex vivo confirmed that the active compounds of the extract, such as eleutheroside M and ciwujianoside B and C3, were able to penetrate the BBB and act on the brain. These three compounds and the leaf extract showed dendritic elongation activity against primary cultured cortical neurons, which may be related to improved memory [ 211 ].
Tests on healthy volunteers have also concluded that the active compounds of eleuthero affect cell defense, physical fitness, and lipid metabolism [ 209 ]. The detoxification properties of the extract have been used in treating chronic lead poisoning in mine workers [ 246 ]. Siberian ginseng has also been used in cosmetics [ 207 ].
The recommended daily dose of eleuthero is 2–3 g of dried root or an equivalent preparation [ 247 ]. According to the Russian Pharmacopeia, a standardized liquid extract of roots and rhizomes of Eleutherococcus senticosus (10 mg of the extract is equivalent to 120 mg of the crude herb) is currently available as an over-the-counter drug in a ratio of 1:1 with 40% ethanol. In the Russian medical system, this extract is recommended for oral use at a daily dose of 20–40 drops for an adult. However, further research is needed to investigate the appropriate dosing regimen to improve healthy adults’ cognitive function and physical performance [ 246 , 248 ]. Side effects occur infrequently. Eleuthero increases blood pressure, so its use in hypertension is not recommended [ 249 ].
Rhizomes and roots from older plants are collected, dried, and subsequently used for extract preparation [ 250 ].
According to an in vitro study, salidroside, a phenylpropanoid glycoside isolated from R. rosea L., showed a protective effect in cultured PC12 neuronal cells against hypoglycemia and serum-restricted cytotoxicity, probably through modulation of gene expression associated with apoptosis, restoration of mitochondrial membrane potential, and inhibition of intracellular oxygen radical production [ 203 ].
An in vivo study was performed to investigate the effects of a single oral dose of an aqueous-alcoholic extract (plant material was extracted with 2% ethanol diluted with tap water) of R. rosea containing 3% rosavin and 1% salidroside on CNS activity in mice. The extract was tested for adaptogenic, antidepressant, anxiolytic, nociceptive, and locomotor activity at various doses using predictive behavioral tests in the animal model. The results showed that this extract significantly induced adaptogenic, antidepressant, anxiolytic, and stimulating effects [ 202 ], but the effects were not dose-dependent.
In a different trial, the effect of R. rosea L. extract on mood, anxiety, stress, and cognition in moderately anxious students was evaluated. Compared with the control, the experimental group showed a significant reduction in anxiety, stress, anger, confusion, and depression, and an improvement in general mood after treatment for two weeks. However, no significant difference in cognitive performance was observed between the groups [ 201 ].
The optimal dose of rhodiola extract for long-term use was 100–170 mg per day, and the rosavin content of the extract should be 3.6–6.14 mg per weight of the extract. This would suggest a daily dose of roughly 360–600 mg of standardized Rhodiola rosea extract containing 1% rosavin [ 251 ].
No serious side effects have been identified so far. Because it affects human nature, it is not recommended for patients who have manic–depressive psychosis. Rhodiola should also not be used by children, pregnant and breastfeeding mothers, or people with high blood pressure [ 252 ].
The often used parts are fruits and seeds. A tincture can be prepared from crushed seeds and a tea brewed from dried berries, shoots, and leaves. The fruits are consumed dried or marinated in sugar or honey to make jam, syrup, juice, or compote. They can also be stored frozen. In addition to syrups and juices, a strong sweet wine can be made from the juice of the berries [ 253 , 254 ]. Schisandra fruits are known to the people of the Far East primarily as a tonic and stimulant against fatigue and exhaustion [ 253 ].
An in vitro study was performed to determine the neuroprotective effects of dibenzocyclooctadiene lignan, schisantherin A, from the fruits of Schisandra chinensis against selective dopaminergic neurotoxin 6-hydroxydopamine-induced neural damage in human neuroblastoma cells. Pretreatment with schisantherin A provided neuroprotection against induced cytotoxicity, regulated the intracellular accumulation of reactive oxygen species and inhibited NO overproduction by reducing the overexpression of inducible nitric oxide synthase in cells [ 206 ].
In other in vitro and in vivo experiments, SH-SY5Y (human neuroblastoma) cells were incubated with 1-methyl-4-phenylpyridinium ion, and mice treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine were used to determine neuroprotection of schisantherin A. Pretreatment with schisantherin A significantly inhibited the induced cytotoxicity in SH-SY5Y cells. In addition, schisantherin A provided significant protection against induced dopaminergic neuronal loss in a mouse model of Parkinson’s disease [ 204 ]. These findings demonstrate that schisantherin A may have potential therapeutic value for oxidative stress-related neurodegenerative disorders, such as Parkinson’s disease [ 204 , 206 ].
In vivo cognitive tests such as the Morris water maze and the passive step-down avoidance tests were performed with rats given oral doses of aqueous or 95% ethanolic extract of Schisandra chinensis (petroleum ether fraction) and showed that the extract could partially reverse the effects of decreasing activity of superoxide dismutase, catalase and the overall antioxidant effect induced by D -galactose, and to maintain normal levels of glutathione, malondialdehyde and nitric oxide in serum, prefrontal cortex, striatum, and hippocampus. The extract improved the overall induced cognitive deficit [ 205 ].
The optimal dose of dried schisandra fruit for human administration is 2–6 g per day. For an average human body weight of 60 kg, the dose is 0.03–0.1 g of fruit per kg of body weight [ 253 , 255 ]. No serious side effects have been reported. Side effects have only occurred after regular ingestion of excessive amounts of fruits and included restlessness and insomnia [ 256 ].
Maca root is consumed either fresh or dried and has a distinctive taste and aroma. In South America, a sweet porridge or pudding called mazamorra de maca is made from dried roots, while the fresh root is cooked like potatoes. It can also be ground into flour, with a composition similar to cereal grains. A slightly alcoholic beverage called maca chica is made from the maca plant. Many growers mix and grind the leaves with the roots [ 257 , 258 ].
Polysaccharide fractions from maca leaves showed different in vitro scavenging capacities on 2,2-diphenyl-1-picrylhydrazyl, hydroxyl, and superoxide anion radicals [ 212 ].
Researchers have recently been interested in the neuroprotective effects of Lepidium meyenii . Experiments in vivo and ex vivo tests have shown the effect of Lepidium meyenii in reducing latency in untrained and trained mice. In the swimming strength test, maca shortened the immobility time. It also increased the uterine weight of mice after ovariectomy. Lepidium meyenii appeared to positively affect latent learning in ovariectomized mice and exhibited antidepressant activity [ 214 ]. Maca improved cognitive function, motor coordination, and endurance in middle-aged mice, increased mitochondrial respiratory function, and upregulated proteins associated with autophagy in the cortex [ 213 ].
These findings suggested that maca might be an effective functional food to slow age-related cognitive decline. The optimal dose has not been determined; however, the amount of maca root powder used in many studies was in the range of 1.5–3 g per day for the average human adult [ 259 , 260 ].
So far, no serious side effects or contraindications to the extracts have been reported. Maca seems to be safe, effective, and non-toxic [ 261 ].
Nootropics are a heterogeneous group of drugs that affect the metabolism of neuronal cells in the central nervous system. They mainly improve cognitive function, especially in cases where there is damage or degeneration. Most of these substances do not have an immediate effect after a single administration and must be used for some length of time before there is a measurable improvement. They are used in acute, subacute, and chronic conditions of memory, consciousness, and learning disorders and as a supportive treatment in patients with Alzheimer’s disease, schizophrenia, hyperkinetic disorder, or senile dementia. Nootropics are usually very well tolerated. Side effects are rare and typically mild, but some complications can occur. For example, people with cardiovascular disease should not use guarana. This is probably due to the relatively high caffeine content. The available literature suggests that the cardiovascular effects experienced by those consuming up to 600 mg of caffeine per day are, in most cases, mild, transient, and reversible, with no permanent adverse effects [ 262 ]. A typical dose of guarana is 75 mg of extract (approximately 12% caffeine) taken as a tablet [ 243 ]. Each such tablet, therefore, contains an average of 9 mg of caffeine. Therefore, in order to get close to the limit of 600 mg of caffeine, a person would have to consume around 66 of these tablets per day. A nootropic that could help in this case is naftidrofuryl, which functions as a vasodilator with rheological effects on the blood and is directly used in treating cardiovascular disorders [ 134 ]. Some nootropics can also affect psychiatric problems; for example, rhodiola is not recommended for patients with manic-depressive psychosis [ 252 ], and dihydroergotoxine is also contraindicated in psychosis [ 153 ]. An expert should be consulted before the use of any of these nootropics. Ginseng and eleuthero are contraindicated in patients with hypertension [ 218 , 219 , 249 ]. Ginkgo causes blood thinning, so people taking certain anticoagulants should not take it, for example, before surgery [ 219 , 225 ]. Additionally, ashwagandha is best taken in the evening because it can act as a sedative in large doses. It is also indicated by its Latin name Withania somnifera, where the Latin species name somnifera means “sleep-inducing” [ 234 ]. Therefore, nootropics users should consider their state of health and mood before deciding to try a certain compound; however, if the recommended dosage is followed, no serious complications should occur. Because of their potential for improving memory and thinking and their easy availability, nootropics have particularly attracted the attention of college students, who call them “smart drugs”. Because of the incomplete clinical evidence on their effectiveness, safety, and social consequences in the case of long-term use, especially with synthetic variants of these drugs, they cannot be recommended to healthy individuals who do not suffer from any cognitive dysfunction. There have not been sufficient experimental studies and results to support prophylactic use, even though the use of herbal supplements with nootropic effects has shown little risk of side effects and contraindications have been minimal. In any case, to be safe, none of these substances should be used during pregnancy or breastfeeding. Future research regarding nootropics should focus on experiments with more diverse human groups, whether in terms of age, health, gender, or weight. It should also mainly focus on young, healthy people, mostly university students, who use these substances a lot and obtain them, especially on the black market. Furthermore, already advanced methods based on neuroimaging assessment should be used more in experiments and studies to confirm or refute the potential beneficial effects.
We thank Gary Bentley for editing and improving the manuscript’s English and Lucie Malá for creating the graphical abstract.
Financial support for publication was from CZ.02.2.69/0.0/0.0/18_054/0014642 project.
Conceptualization, M.M.; formal analysis, M.M.; writing—original draft preparation, M.M.; writing—review and editing, M.M. and P.T.; visualization, M.M.; supervision, P.T.; project administration, P.T. All authors have read and agreed to the published version of the manuscript.
Informed consent statement, data availability statement, conflicts of interest.
The authors declare no conflict of interest.
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Whether you're a college student hoping to ace your exams, a busy professional striving for a promotion, or an older adult concerned about dementia , the idea of popping a pill that boosts your brainpower might seem appealing. So perhaps it's not surprising that the use of nootropics -- aka cognitive enhancers or smart drugs -- is on the rise. But do they work? And are they safe?
The term "nootropics" first referred to chemicals that met very specific criteria. But now it's used to refer to any natural or synthetic substance that may have a positive impact on mental skills. In general, nootropics fall into three general categories: dietary supplements , synthetic compounds, and prescription drugs.
While health experts generally agree that taking a prescription nootropic for an FDA-approved purpose (such as a stimulant medication if you have ADHD or donepezil if you have Alzheimer’s) may be helpful, the use of any type of cognitive enhancer in healthy people is far more controversial.
Barry Gordon, MD, PhD, director of the cognitive neurology/neuropsychology division at Johns Hopkins Medicine, says there's "no strong evidence" that any of the supplements now being sold for their supposed memory-boosting powers are helpful. "It's not clear that they work and not clear that they're safe," he says. He’s also skeptical of the basic premise behind nootropics.
"The circuits that are involved in human cognition are very complicated and not fully understood," he says. "You can't just 'turn up the dial' that easily." He notes that people who believe their mental performance has increased thanks to nootropics are largely being influenced by a placebo effect. "If you're more confident and think you'll do better, you will do better."
Chris D'Adamo, PhD, director of research and education at the University of Maryland’s Center for Integrative Medicine, has a different take. Like Gordon, he doesn't think nootropics will give you superhuman mental abilities, but he does believe they have the potential to offer some people an edge.
"Most people seeking to optimize cognitive function would be better off focusing on getting enough sleep , eating a nutrient-dense diet , and managing their stress ," he says. But once you have those basics down, the right nootropics might serve as a bonus, helping you think more clearly and sharply or reduce your chances of cognitive decline as you age, he says.
Almost everyone uses a nootropic, whether they know it or not, says D'Adamo. He's talking about caffeine , and while it can have health risks if you overdo it, this natural stimulant has been shown to improve thinking skills. It doesn't simply make you feel more alert, says D'Adamo: Caffeine also gives you more access to several chemicals (neurotransmitters) in your brain such as acetylcholine, which helps with short-term memory and learning.
But most people interested in nootropics aren't sticking to coffee or tea. They’re branching out to dietary supplements. Some, such as ginseng and gingko, have not held up to scientific scrutiny. Yet others -- including CDP-choline, L-theanine, creatine monohydrate, Bacopa monnieri , huperzine A, and vinpocetine -- may still hold promise.
Racetams, such as piracetam, are another type of nootropic. You can get these synthetic compounds over the counter in the U.S., but they’re considered prescription drugs in some other countries. D'Adamo says these chemicals, which act on neurotransmitters including acetylcholine, have been studied in older adults who have a decline in thinking skills. He doesn’t recommend them for most younger, healthy people.
Prescription nootropics largely consist of stimulants such as those in some ADHD medications . Although these work well for many people with ADHD , they are not recommended for others who simply want to improve their focus and attention. Many college students get these types of drugs illegally, and while they may seem to help in the short term, there are serious risks. Side effects may include insomnia , blurry vision , high blood pressure , a fast heart rate , circulation problems, and addiction .
Another type of prescription nootropic is modafinil ( Provigil ). It's FDA-approved to treat narcolepsy, sleep apnea , and shift work disorder, but some studies suggest that it may help with learning and memory in healthy people. Modafinil appears to be safer than other types of stimulants, but more research is needed.
If you're considering trying nootropic supplements, you should talk it over with your doctor first. As with all supplements, you’ll want your doctor to let you know about any health risks, like effects on any conditions you have or medications you take.
Keep in mind that although there are some studies on the topic, they tend to be small or limited to the impact on older adults. Also, everyone's brain chemistry is unique, so what works for one person might not for another, says D'Adamo. That said, these four types might have promise:
L-theanine: This supplement seems to enhance the mental effects of caffeine and counteract caffeine -induced jitteriness, D'Adamo says. Research has shown that combining caffeine and L-theanine may help you multitask better. The safest way to get this combo is by drinking pure green tea, which contains both caffeine and L-theanine, but it's also OK to combine your usual coffee or tea with an L-theanine supplement.
Don't take caffeine in pill or power form, as it's too easy to overdo it. Caffeine, in excess, can be toxic, causing a racing heartbeat and even leading to seizures or death. Just 1 teaspoon of pure caffeine powder could have as much caffeine as you’d get from 28 cups of coffee. The FDA, which has cracked down on makers of pure and highly concentrated caffeine products, notes that the difference between a safe amount and a toxic amount is very small.
CDP-choline: Often prescribed in Europe as a drug, CDP-choline has been shown to help memory -- at least in people who have dementia caused by vascular problems in the brain. There are no known side effects, so it's generally considered safe to try.
Creatine monohydrate: Frequently found in body-building supplements, creatine helps build muscle mass. But studies have also found that it may improve reasoning skills and short-term memory in healthy people. It increases levels of a molecule called ATP, which leads to more cellular energy, D'Adamo says. "I take it regularly just for energy. It's very safe." But talk to your doctor first if you have any kidney problems.
Bacopa monnieri : A traditional Indian (ayurvedic) herb, Bacopa monnieri -- also known as brahmi -- has been suggested by some to help the brain processes information faster. It causes the branches of nerve cells (dendrites) to grow, says D'Adamo. He says this process takes some time; expect to wait 4-6 weeks for results. Although it's generally well-tolerated, it may cause abdominal cramping, nausea, and diarrhea.
While combining several of these supplements might seem like a good idea -- and many formulas on the market that do just that -- D'Adamo doesn't recommend it because most of the combos haven't been well-studied. Instead, he suggests trying one or two for a few months, then taking a month off before going back on them or switching to others. His concern is that you can become tolerant to nootropics (including caffeine), which means you'll need more and more for them to work for you.
As with any dietary supplements, you should also keep in mind that the FDA doesn’t closely regulate nootropic supplements the way it does prescription drugs. Look for reputable brands and trust your body: If you notice any side effects or don't see an improvement in the expected timeframe, it's wise to stop.
Find more top doctors on, related links.
Is it safe to take thesis nootropics (energy blend) and 20mg vyvanse at the same time.
Mushroom edibles are making people sick. scientists still don't know why, scientists aim to find out why mushroom edibles are making people sick.
Dr. Roy Gerona contracts with the Drug Enforcement Administration and has been investigating a string of illnesses from mushroom gummies. Preston Gannaway /for NPR hide caption
Dr. Michael Moss couldn’t explain why the man in his hospital’s ICU had started convulsing after trying a chocolate bar, but he knew there was more to the story.
The patient recounted eating a mushroomed-infused candy, packaged with trippy artwork — and purchased legally at a local store.
He’d been flown in over the weekend from a rural hospital to the University of Utah Hospital in Salt Lake City, where Moss, a toxicologist, is medical director of the Utah Poison Control Center.
“This was crazy,” he said to himself. “Nobody gets put on the ventilator and has a seizure from eating psychedelic mushrooms.”
Alarmed, he began contacting poison centers around the country and soon discovered similar cases were popping up: Patients with nausea, vomiting, agitation, seizures, loss of consciousness and other symptoms.
There are now more than 140 documented illnesses — including two suspected deaths — all tied to the same brand of mushroom edibles, called Diamond Shruumz, according to the Food and Drug Administration.
It’s one of the many varieties of psychedelic-inspired treats that have proliferated online, in smoke shops and convenience stores, often advertising some kind of proprietary mushroom blend, with words like “nootropic,” “magic” or “microdosing” emblazoned on the packaging.
Prophet Premium Blends, the company that makes Diamond Shruumz, said in a recall notice that it has ceased production and distribution of the products, citing “toxic levels of muscimol .”
Muscimol is a compound in the iconic red-capped mushroom, Amanita muscaria , and was identified by the company as a “potential cause” of the sickness, the recall notice said. The company did not respond to multiple requests for comment.
In spite of the recall, poison centers are still receiving calls, albeit at a slower pace than earlier in the summer, says Kaitlyn Brown , clinical managing director for America's Poison Centers.
While also psychoactive, the Amanita species has quite different effects from the famous (and mostly illegal) psilocybin-containing magic mushrooms and has gained more popularity lately , buoyed by the fact that it’s not a controlled substance.
Yet it’s still not clear that the colorful mushroom is to blame for the illnesses.
According to an ongoing FDA investigation, initial testing has turned up an array of other substances in the recalled products, and muscimol in less than half of them.
At this point, experts say none of the findings adequately explain why people are getting so sick. “We still don't know the culprit,” says Moss. “These products are living in this very strange legal gray area .”
The rise of these unregulated psychoactive products is reminiscent of the boom in synthetic cannabis years back, except now hallucinogenic drugs are increasingly “in fashion,” says Roy Gerona , a chemist at the University of California, San Francisco who runs a toxicology lab that works with the Drug Enforcement Administration.
The federal investigation into Diamond Shruumz products hasn't yet pinned down what's responsible for the illnesses. Preston Gannaway/for NPR hide caption
Figuring out what’s actually in these candy bars and gummies is proving to be quite tricky.
“The analysis itself is very challenging,” says Gerona. “That's the reason why it's taking a little longer than what the public is used to.”
The difficulties are manifold: Most toxicology labs didn’t have Amanita muscaria on their radar as they would for common street drugs. Even Gerona’s lab that specializes in responding to mass poisonings and detecting designer drugs had to hurry to develop accurate tests.
Beyond that, analyzing something like a chocolate bar is no easy task — and it’s especially difficult to detect muscimol and ibotenic acid, two of the potentially toxic compounds.
But what testing has turned up so far is concerning.
The federal investigation of Diamond Shruumz has found a synthetic version of psilocybin, 4-AcO-DMT , which is not a controlled substance but could be considered illegal under federal law because of its similarity to psilocybin. There are other substances, too, like the anticonvulsant drug pregabalin, which is sold under the brand name Lyrica, and the herbal supplement kava .
The mix of chemicals isn’t all that surprising to Dr. Avery Michienzi , a medical toxicologist at the University of Virginia, who responded to a separate cluster of illnesses about a year ago.
Her analysis of similar products — five brands of mushroom gummies — from smoke shops in Charlottesville found psilocin, ephedrine and the natural plant kratom , which has opioid-like properties.
“People may be intentionally seeking out the psychedelic experience, but getting more than they bargained for,” she says. “It’s scary they’re buying this stuff when they really don’t know what’s in there.”
The market appears to be growing. During surveillance of online tobacco retailers, Eric Leas , an epidemiologist at the University of California, San Diego, noticed an uptick in public interest in these products, which are sometimes sold alongside delta-8, a psychoactive substance derived from hemp, and herbal supplements.
“This is an investigation of one company, but there's hundreds selling these products,” says Leas.
Over the past year, Caleb King and Christopher Pauli have compiled a growing list of chemicals in various mushroom products.
“People are throwing the kitchen sink into some of these and calling them a natural blend,” says King, who along with Pauli runs Tryptomics , a company that tests for psychoactive substances in natural products.
The duo has examined more than 100 of these edibles — largely at the request of consumers — and has found herbal supplements, amphetamines and synthetic chemicals that are essentially spinoffs of popular hallucinogens.
“I’m seeing compounds that I had not seen yet, and we're rapidly trying to discover what they are,” says King.
What’s clear from the work done by Tryptomics is that there’s little in the way of consistency. The same type of edible can contain different ingredients and at varying concentrations. Counterfeits abound, especially with popular brands, says Pauli.
Gerona runs the UCSF Clinical Toxicology and Environmental Biomonitoring Lab, which focuses on detecting new psychoactive substances. Preston Gannaway/for NPR hide caption
Gerona, who has written a book on designer drugs, says his lab is still doing testing and trying to figure out the amount of muscimol in the products. That said, he’s keeping an open mind about the illnesses linked to Diamond Shruumz, including the possibility that a new psychoactive substance could be involved
“None of the data fully explains the symptoms yet,” says Gerona. “Some of us are asking ourselves, what are we missing here?”
A mushroom takes center stage.
The mounting safety concerns are bringing new visibility to Amanita muscaria itself.
The mushroom has plenty of folklore surrounding it and was used medicinally in Eastern Europe, Scandinavia and other regions for hundreds of years, though nowadays most recognize it thanks to depictions in popular culture, from Alice in Wonderland to Super Mario to the mushroom emoji.
The compounds work on different receptors than psilocybin. Given the effects, it tends not to have a "high recreational potential,” says Kevin Feeney , a cultural anthropologist at Central Washington University who’s edited a compendium on Amanita muscaria , also known as fly agaric.
People often seek out the mushrooms for microdosing and believe it helps with anxiety, sleep and even more serious problems like addiction to benzodiazepines and alcohol, Feeney says. But there’s little evidence from clinical research on its possible therapeutic benefits in humans.
Christian Rasmussen, who sells Amanita muscaria online, likes to call it the “Santa Claus mushroom” because, in lower doses, it has a “light and jolly” quality, without the feeling of inebriation.
An avid believer in its healing properties, he credits the mushroom for “saving his life” when he was getting off benzodiazepines after years of addiction, and now he runs MN Nice Botanicals .
Still, Feeney cautions, taking the mushrooms at high doses “can be incredibly unpleasant and disturbing.” It provokes a “dissociative, dream-like state,” the closer comparison being ketamine rather than psilocybin, adds Rasmussen.
Amanita muscaria — also known as fly agaric — is attracting more interest, but those familiar with the mushroom caution it's a far cry from a psilocybin mushroom trip. Karl-Josef Hildenbrand/DPA/AFP via Getty Images hide caption
The Amanita muscaria mushroom is poisonous, but there are not many documented reports of overdose and death. People who eat small amounts are unlikely to get very sick. In concentrated doses, at least two compounds in the mushroom can cause serious health problems, says Moss, who has studied its toxicity . (He warns it can sometimes be confused with other, more deadly species of Amanita .)
Muscimol has a sedating effect because it’s similar to the neurotransmitter GABA and can cause loss of consciousness or even a coma. The other, ibotenic acid, is a neurotoxin that can lead to hallucinations, delirium and, in rare cases, even seizures.
Together, large doses of both might help explain some of the illnesses, but testing for ibotenic acid is difficult, notes Gerona.
That compound has not shown up in the Diamond Shruumz edibles yet, although it has appeared in the raw ingredients (along with muscimol) that were reportedly used in some of the products, according to the FDA.
The marketing of products touting Amanita strikes Feeney as essentially a “bait and switch,” with manufacturers drawing customers in under the guise of a legal substance.
This bothers people who believe in the mushroom’s health potential. Rasmussen says he noticed what he calls “the smoke shop industry” getting into the Amanita business about three years ago, eyeing it as the next delta-8, which is derived from hemp and sold legally.
“I told them from the beginning, that's not what this is,” he says.
Jeff Stevens worries that the confusion over what’s driving the illnesses could lead to a regulatory backlash.
His publicly traded company, Psyched Wellness , began selling Amanita muscaria tinctures in supplement stores a few years ago, after “spending millions of dollars on preclinical studies.”
While they’re not required to submit data to the FDA, he says their findings were reviewed by a panel of experts in accordance with federal regulations .
Their mushrooms come from foragers in Eastern Europe, are tested by a third party lab and undergo an extraction process to convert most of the ibotenic acid into muscimol, he says. (Feeney is on the company's advisory board.)
“My concern would be if there is a knee-jerk reaction on regulatory enforcement with all Amanita without taking the time to understand what caused the issues [with Diamond Shruumz] and considering how this mushroom can be used safely,” he says.
A deep freezer stocked full of biological samples from overdose cases at the toxicology lab at UCSF. Preston Gannaway/for NPR hide caption
For now, though, there’s little to help the average consumers navigate the bewildering market that’s sprouted up around these mushroom products.
King at Tryptomics says he wouldn’t recommend trying them without testing what’s in there first. Look for QR codes on the packaging that pull up the actual results, what’s known as a certificate of lab analysis, which should be housed on the lab’s website. But Pauli warns sometimes those documents can be fake, or the analysis may only list the substances that are not present, rather than what’s in there.
“That's a huge issue,” says Pauli.
In a few instances, King says manufacturers have asked them to test a white powder that was bought from overseas under the impression it was muscimol, only to discover it’s actually an amphetamine-based substance.
Like any industry there are “good and bad actors” who are manufacturing and testing these products, says Roger Brown , CEO of ACS Laboratory, which is licensed by the DEA and tests products containing cannabis, muscimol and other compounds.
“ We produce the results — whether the results are good or bad for the client, we don't judge that,” he says.
He’s candid about the gaps in oversight.
“When you buy a gummy bear that's got Amanita muscaria in it, nobody's regulating it, or if they are regulating it, they're not enforcing it .”
Safe Bulkers, Inc. ( NYSE: SB ) ( NYSE: SB.PR.C ) ( NYSE: SB.PR.D ) is a global provider of dry bulk transportation services, specializing in the larger, gearless vessel classes (Panamax, Kamsarmax, Post-Panamax, and Capesize types) and transporting key commodities like coal, grain, and iron ore.
The last time I wrote about SB (and preferred shares) was at the end of March 2023, more than a year ago. Since then, the common stock's total return amounted to about 48%, outperforming the broader market represented by the S&P 500 index ( SP500 ) by ~650-700 basis points:
Seeking Alpha, Oakoff's coverage of SB and preferred shares
Back then, a year ago, I argued that Safe Bulkers was well-positioned to outperform market expectations amid improving prospects in the dry bulk shipping sector in general; driven by rising demand, SB stood out as the most undervalued stock among its peers. For income-seeking investors, the preferred stock was also a compelling choice, offering a forward yield of around 8.1% at the time while mitigating some of the company's risks. Time has shown that my bullish call was spot on.
Today, my old thesis changed a bit: I still think that Safe Bulkers can offer solid returns because the company's business is still thriving thanks to a strong market environment. However, I have some doubts that these market conditions are likely to continue at least until the end of next year, so income-seeking individuals (preferred shares investors) seem to be way more protected than common stock buyers. So I downgrade SB common stock to "Hold", maintaining my "Buy" rating for SB's preferred shares.
In Q2 2024 , Safe Bulkers reported $78.5 million in net revenue, marking an 11% YoY increase - that was primarily driven by "higher charter rates and increased earnings from vessels equipped with scrubbers," which benefit from the price differential between heavy fuel oil and compliant fuel, according to the press release commentary . The average time charter equivalent (TCE) rate rose to $18,650, up from $17,271 in the previous year, while the daily vessel OPEX excluding dry-docking and pre-delivery costs went up by just 1% QoQ (being down 2.6% YoY), which helped SB to make 43% more in EBITDA than last year.
SB's latest 6-K
As a result, SB's net income for Q2 amounted to ~$27.6 million, a significant increase from $15.4 million in Q2 2023 (+79.2% YoY actually). As the press release noted, this rise in profitability can be attributed to the "stronger charter market environment, gains from the sale of older vessels, and the strategic deployment of the fleet." Indeed, the dry bulk market was primarily driven by a combination of resilient demand and limited supply during Q2, which helped support freight rates. The Baltic Dry index pushed up from the 2023 lows driven by stronger capesize demand, making a 6x comeback in Q4 2023, but then giving up some of its gains; however, it's still trending up, looking relatively good during the seasonally weak Q2:
TradingEconomics, Baltic Dry Index
I believe that the overall demand for dry bulk transportation should remain strong going forward, bolstered by economic activities in major economies such as China and India. It's not just that Q3 is generally seasonally better than Q2 - I'm talking primarily about the whole of 2H 2024. Although a slowdown in demand growth is forecast, overall, it is likely to remain at a relatively high level over the next few months, meaning that Safe Bulkers' focus on decarbonizing the fleet and energy-efficient newbuilds should bear fruit against this backdrop.
SB's IR materials, Oakoff's notes added
Safe Bulkers' management expects strong freight rates next year due to limited new ships and steady demand, with growth in iron ore and grain shipments, but a decline in coal shipments. BIMCO's analyst - Niels Rasmussen - whose opinion I always listen to, is more pessimistic about the dry bulk shipping industry, noting that the strong market in 2024 may cool as 2025 nears.
We expect the supply/demand balance to strengthen in 2024 but weaken in 2025. Supply is estimated to grow by 3-4% in 2024 and 1.5-2.5% in 2025, while demand is projected to grow by 4.5-5.5% in 2024 and weaken by 1-2% in 2025.
If there are indeed problems with demand in the market next year, then I expect that SB common stock may continue its correction (it's currently ~21% off its local peak).
For holders of preferred shares, however, it is sometimes important to pay attention to slightly different key figures. Safe Bulkers maintained a solid liquidity position with $81.6 million in cash and cash equivalents as of Q2, alongside $179.5 million in undrawn borrowing capacity, thus providing financial flexibility for future investments and operations. At the same time, the company's EBITDA has grown the fastest compared to other competitors in the recent past, which in my opinion says something about the effectiveness of business process management.
Furthermore, I see no problems in covering the preferred dividends in the future: at the time of Q2, SB could comfortably cover the preferred dividend payments, earning almost 14 times the income required to do so (last year this figure was only 7.6).
SB's recent 6-K, Oakoff's notes added
To come back to the common shares: I think they are quite undervalued, even compared to SB's closest publicly traded peers. However, if we add the debt-to-equity ratio to the usual EV/EBITDA ratio comparison, we'll see that the current comparative undervaluation is perhaps justified by the higher debt burden. However, the interest expense itself appears to be limited, which again speaks in favor of protection for preferred shareholders.
YCharts, Oakoff's notes added
Talking about the valuation of SB.PR.C and SB.PR.D, which yield 7.84% and 7.79% , respectively (on a forward basis), I think we can say that they are quite fairly valued today. These preferred shares were issued at $25/sh., which is roughly where they are now (with a small premium), having fully recovered from the COVID slump.
Preferred Stock Channel
Why do I say they are fairly valued despite the small premium? My first guess is that the recent macro data will not allow the Fed to delay rate cuts for too long. Money is getting "cheaper" again, so to speak, which should make assets that offer yields as high as SB's preferreds more attractive.
From all this, I conclude that while SB's business is growing quite rapidly, with prospects for the rest of 2024, I definitely see risks of a supply/demand imbalance next year. If these risks materialize, today's expectations for a decline in earnings per share in 2025 may turn out to be underestimated.
Seeking Alpha
At the same time, I see no risk to the dividend payments on the preferred shares - even if earnings per share fall several times from here, SB will be able to pay the dividends on its preferreds. In this context, I like SB.PR.C because of its higher liquidity compared to SB.PR.D.
That's why I'm downgrading SB common stock to "Hold" today, maintaining my "Buy" rating for SB's preferred shares.
Good luck with your investments!
With just one subscription to Beyond the Wall Investing , you can save thousands of dollars a year on equity research reports from banks. You'll keep your finger on the pulse and have access to the latest and highest-quality analysis of this type of information.
This article was written by
Oakoff Investments is a personal portfolio manager and a quantitative research analyst with 5 years helping readers find a reasonable balance between growth and value by sharing proprietary Wall Street information.
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
About sb stock.
Symbol | Last Price | % Chg |
---|
Symbol | Last Price | % Chg |
---|---|---|
SB | - | - |
SB.PR.C | - | - |
SB.PR.D | - | - |
Trending news.
COMMENTS
This powerful nootropic blend is specifically designed to increase energy, overcome fatigue, and build mental stamina. Thesis Energy is caffeine-free, making it a great option for those who are sensitive to caffeine or looking for a natural alternative to traditional energy drinks.
Thesis Nootropics' clarity formula provides an extra boost of cognitive performance, targeting stress response reduction and improving sleep quality, all while delivering a healthy dose for enhanced mental clarity and improved ability. ... Yes, it is safe to take Thesis Nootropics every day. We found Thesis to be generally easy to process, but ...
Thesis Overview. 4.7/5. ★★★★★. Price: $119 for one-time purchase or $79 with subscription. Helps With: Cognitive function, including motivation, memory, focus, and more. Side Effects: Headache, stomachache, and more. Safety: Made with ingredients that are Generally Recognized As Safe (GRAS) by the FDA or have passed Phase III clinical ...
Most of the ingredients that Thesis uses in their nootropics exhibit minimal side effects in clinical research, so there's a good chance that Thesis' various formulas will be safe for most people. But Thesis has nearly three dozen ingredients in their catalog, and not all of them will be safe for all users, including those who are pregnant or ...
Most natural nootropics are generally regarded as safe. However there are potential side effects and interactions when taking certain medications. ... When looking for an online source for nootropics, look no further than Thesis. Thesis goes through a rigorous 4 phase process that entails clinical research review, blend formulation, and ...
Establishing Natural Nootropics: Recent Molecular Enhancement Influenced by Natural Nootropic. Evid Based Complement Alternat Med. doi: 10.1155/2016/4391375. Todorova, V. (2021).
We'll do our best to make any updates to your order before it has left our fulfillment center. The fastest way to contact us is by calling 646-647-3599 between 10 am - 5 pm ET or sending us an email at [email protected], with your order number, original shipping address, and the new address you wish to change to.
Thesis nootropics are probably the best way to get into nootropics without having to do loads of research. The brand isn't the cheapest out there, but the product is quality and the customer service is excellent. References. Lai, Puei-Lene et al (2013) https://pubmed.ncbi.nlm.nih.gov/24266378/
Caffeine: Investigations affirm it's generally safe in moderate amounts; however, excessive intake can lead to side effects. ... Thesis Nootropics have been met with a broad spectrum of feedback from users who typically emphasize gains in focus, clarity, and energy levels. Below is a curated selection of customer testimonials:
Thesis is a nootropic company that offers personalized blends for your brain goals and lifestyle. Whether you want to boost your focus, creativity, mood, or energy, you can find the right formula for you. Try their starter kit and get free shipping, coaching, and a 30-day guarantee.
The Motivation formula is intended to boost willpower and productivity while reducing procrastination. This formula from Thesis includes the following nootropic ingredients: Artichoke extract, for ...
The regular one-month supply of Thesis Nootropics is $119 ($3.97 daily), but you can save $40 by choosing the Subscribe & Save option, which brings it down to $79 per month ($2.63/day) . This is a pretty expensive line of nootropics, but they are meant to be all-inclusive.
It's safe to say that after two days of use, you'll know which Motivation camp you fall into. ... Thesis Nootropics Review: Boosting Your Brain With Precision Formulas. Ignore those that say you're stuck with a less-than-optimal brain. According to the latest neuroscience (and countless personal examples), that's demonstrably false. ...
Our research team reviews the ingredients in Thesis nootropics to give our take on whether the supplements are likely to be effective. We share our concerns about the brand's marketing practices and health data collection. ... Most of the active ingredients in Thesis supplements appear to be safe and well-studied. We don't have access to the ...
Discover personalized nootropics for brain support in our Thesis Nootropics review. With 96% purported customer satisfaction, Thesis...
Thesis Clarity. Based on Take Thesis reviews, the goal of Clarity is to sharpen your focus and clear your brain fog, which could help you think better. It combines natural ingredients - like 7,8 ...
Conclusion. Nootropics are safe if you have an awareness of risks and how to avoid them. There is always a risk that you will have edge-case side effects. To avoid these, start with small dosages ...
Thesis Nootropics, with its perfect blend of proven and natural ingredients, offers just that. Whether you're a student, a working professional, or someone looking to delay age-related cognitive decline, understanding the ingredients and their benefits is the first step in making an informed choice. ... Is it safe? For the most part, users of ...
Thesis has potent, safe, and effective nootropics that can help you achieve your best self. Affiliate Disclosure: ... Thesis nootropics is a nootropics brand that offers personalized cognitive enhancement solutions. The personalization aspect is the key here, as most other nootropic brands are not so hands-on with customer support. ...
Nootropics tend to be well tolerated in patients with cognitive impairments; the incidence of side effects is low, and those that do occur are usually mild [4,5,6]. ... Meclofenoxate is deemed to be safe and tolerable. Possible side effects are often caused by overdose, including dizziness, restlessness, nausea, and headache [58,60].
Discussion of nootropics and cognitive enhancers. I tried Thesis. Don't waste your money. I'm a naturally caffeinated guy, so I was disappointed that all Thesis blends contain caffeine. I don't think they made a difference for me. I took. To be honest I've had more success with pre-workouts.
The term "nootropics" first referred to chemicals that met very specific criteria. But now it's used to refer to any natural or synthetic substance that may have a positive impact on mental skills ...
Thoughts on Thesis Nootropics? Archived post. New comments cannot be posted and votes cannot be cast. To add, the cost for 4 packs is $120. From screenshots taken, the "Energy" supplement pack ingredients are: Choline, Zynamite, TeaCrine, NAC, Sabroxy, NALT, Caffeine, and L-Theanine. Obviously cheaper to DIY the stack, but I'm curious if anyone ...
Beginner's Guide • Vendor Warnings • Research Index • Rules • Longevity • Nootropics. Before posting make sure your comment is polite and helpful. Be aware that anecdotes, even your own anecdote could be an artifact of your beliefs. The placebo effect is just one way that suggestion affects our experience. Humans are social animals ...
A wave of illnesses is bringing scrutiny to a murky marketplace of mushroom gummies and candy. But is a popular red-capped fungus really to blame? Testing shows there's more going on.
bfk92. My Thesis Update. Safe Bulkers, Inc. (NYSE:SB) (NYSE:SB.PR.C) (NYSE:SB.PR.D) is a global provider of dry bulk transportation services, specializing in the larger, gearless vessel classes ...